Beyfortus 100 MG/ML syringeml
Ended Awarded
- Contract number
- SPE2DB26FGVAQ
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $3,416
Award facts
- Contract value 100% obligated
- $3,415.68 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $3,415.68 firm fixed-price delivery order to AmerisourceBergen Drug Corp on October 17, 2025, for Beyfortus 100 mg/mL syringes. This is a non-set-aside competitive award with an ultimate completion date of October 20, 2025, and will be performed at the company's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026, which serves as a comprehensive global pharmaceutical support vehicle enabling the supply of a vast range of pharmaceutical products and medical supplies to support military healthcare programs worldwide.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal vendor serving the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's extensive federal contract portfolio demonstrates its capability to supply brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains through competitively awarded delivery orders with firm fixed pricing. Beyfortus is a respiratory syncytial virus (RSV) monoclonal antibody used for immunoprophylaxis in infants and young children, reflecting the company's role in supplying specialized pharmaceutical products to support military healthcare operations.
Quick answers
Who was awarded contract SPE2DB26FGVAQ?
SPE2DB26FGVAQ was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 17, 2025.
How much is contract SPE2DB26FGVAQ worth?
The government has obligated $3,416 on SPE2DB26FGVAQ.
Is contract SPE2DB26FGVAQ an order under another contract?
Yes. SPE2DB26FGVAQ is a delivery order under SPE2DB24D2213, an indefinite delivery contract.
Was contract SPE2DB26FGVAQ competed?
The extent of competition for SPE2DB26FGVAQ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award